Cargando…
Erythrocyte membrane-camouflaged nanoparticles as effective and biocompatible platform: Either autologous or allogeneic erythrocyte-derived
Erythrocytes are often used for the development of cell membrane camouflaged nanoparticles (NPs) due to their wide range of sources. However, whether the difference between autologous and allogeneic sources for the erythrocyte membranes have an influence on the performance of camouflaged NPs, which...
Autores principales: | Dai, Jun, Chen, Zhaojun, Wang, Shixuan, Xia, Fan, Lou, Xiaoding |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9119842/ https://www.ncbi.nlm.nih.gov/pubmed/35601893 http://dx.doi.org/10.1016/j.mtbio.2022.100279 |
Ejemplares similares
-
Biocompatible Assessment of Erythrocyte Membrane-Camouflaged Polymeric PLGA Nanoparticles in Pregnant Mice: Both on Maternal and Fetal/Juvenile Mice
por: Chen, Sailing, et al.
Publicado: (2022) -
Preparation and Characterization of Erythrocyte Membrane-Camouflaged Berberine Hydrochloride-Loaded Gelatin Nanoparticles
por: Su, Jing, et al.
Publicado: (2019) -
Erythrocyte–Cancer
Hybrid Membrane-Camouflaged
Prussian Blue Nanoparticles with Enhanced Photothermal Therapy in
Tumors
por: Liu, Zhining, et al.
Publicado: (2023) -
Tumor targeted cancer membrane-camouflaged ultra-small Fe nanoparticles for enhanced collaborative apoptosis and ferroptosis in glioma
por: Wang, Jingchen, et al.
Publicado: (2023) -
Bone-targeted erythrocyte-cancer hybrid membrane-camouflaged nanoparticles for enhancing photothermal and hypoxia-activated chemotherapy of bone invasion by OSCC
por: Chen, Hongying, et al.
Publicado: (2021)